ICU · GI & nutrition / surgical
Abdominal Sepsis & Peritonitis — Source Control, SBP & the Polymicrobial
Also known as Peritonitis · Abdominal sepsis · Intra-abdominal sepsis · Spontaneous bacterial peritonitis · SBP · Secondary peritonitis · Tertiary peritonitis · Source control · Peritonism · Piperacillin-tazobactam · Metronidazole · Complicated intra-abdominal infection · cIAI · Damage control laparotomy · Mannheim Peritonitis Index · Hepatorenal syndrome
The peritonitis is the inflammation of the peritoneum, usually from the intra-abdominal infection; the abdominal sepsis is the sepsis from the intra-abdominal source. The three types: the primary (the spontaneous bacterial peritonitis — the SBP in the cirrhosis and the ascites, the monomicrobial, the ascitic PMN over 250 cells per cubic mm, the cefotaxime plus the albumin), the secondary (the GI perforation or the ischaemia, the polymicrobial — the Gram-negative and the anaerobes, the source control plus the antibiotics), and the tertiary (the persistent or the recurrent after 48 hours of the failed initial treatment, the resistant — the Enterococcus, the Candida, the MDR organisms). The diagnosis: the peritonism (the rigid abdomen, the guarding, the rebound), the CT (the gold standard — the free gas, the fluid, the source), the lactate, the cultures. The management: the Sepsis-6 bundle, the broad antibiotics (the piperacillin-tazobactam ± the vancomycin ± the antifungal, or the ceftriaxone plus the metronidazole or the meropenem), the duration 4 to 7 days after the source control, and the SOURCE CONTROL (the surgery or the IR — the drainage, the debridement, the repair) — the definitive; the delayed source control worsens the mortality.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Secondary peritonitis needs SOURCE CONTROL — antibiotics alone fail; early treatment with the shortest delay possible improves outcome
- SBP = ascitic PMN at or over 250 cells/mm³; treat with cefotaxime (2 g twice daily as effective as higher dosing) PLUS albumin 1.5 g/kg at diagnosis then 1 g/kg on day 3 (renal impairment 33 to 10 percent)
- Tertiary peritonitis = persistent/recurrent after 48 h — MDR organisms (Enterococcus, Candida, Pseudomonas); exclude an undrained source before blaming it
- Free intraperitoneal gas + peritonism = perforated viscus — emergency source control
- Antibiotic course is about 4 days AFTER adequate source control (STOP-IT) — prolonged courses do not improve outcome
- Add antifungal for intra-abdominal Candida risk (post-op, immunocompromise, necrotising pancreatitis, prolonged antibiotics, recurrent)
- C. difficile is the hidden cause of post-operative ileus/leucocytosis — send GDH + toxin in every post-op deterioration
- Abdominal compartment syndrome can complicate severe peritonitis — measure intravesical pressure if oliguric + tight abdomen
Meet the patient
A 64-year-old man arrives rigid and guarding after two days of diverticular pain that suddenly generalized. He is cold, tachycardic, lactate 4.2, and the erect chest X-ray shows free gas under the right hemidiaphragm. The registrar reaches for antibiotics; the consultant is already calling theatre.[7]
The single decision that decides this man's survival is not which antibiotic — it is how fast the perforation is controlled. Antibiotics buy time; the operating theatre buys life. Hold that inversion and the whole topic falls into place.[1]
References25ShowHide
- [1]Bova R, Griggio G, Vallicelli C, et al. Source Control and Antibiotics in Intra-Abdominal Infections. Antibiotics (Basel), 2024.PMID 39200076
- [2]Sartelli M, Chichom-Mefire A, Labricciosa FM, et al The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections. World Journal of Emergency Surgery, 2017.PMID 28702076
- [3]Sawyer RG, Claridge JA, Nathens AB, et al Trial of short-course antimicrobial therapy for intraabdominal infection. New England Journal of Medicine, 2015.PMID 25992746
- [4]Sort P, Navasa M, Arroyo V, et al Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. New England Journal of Medicine, 1999.PMID 10432325
- [5]Runyon BA (AASLD Practice Guidelines Committee) Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology, 2013.PMID 23463403
- [6]Solomkin JS, Mazuski JE, Bradley JS, et al Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clinical Infectious Diseases, 2010.PMID 20034345
- [7]Evans L, Rhodes A, Alhazzani W, et al Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine, 2021.PMID 34605781
- [8]Linder MM, Wacha H, Feldmann U, et al [The Mannheim peritonitis index. An instrument for the intraoperative prognosis of peritonitis]. Chirurg, 1987.PMID 3568820
- [9]Mazuski JE, Tessier JM, May AK, et al The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. Surgical Infections, 2017.PMID 28085573
- [10]Lamme B, Boermeester MA, Reitsma JB, Mahler CW, Obertop H, Gouma DJ Meta-analysis of relaparotomy for secondary peritonitis. British Journal of Surgery, 2002.PMID 12445059
- [11]Bassetti M, Marchetti M, Chakrabarti A, et al A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Medicine, 2013.PMID 24105327
- [12]Fernández J, Tandon P, Mensa J, Garcia-Tsao G Antibiotic prophylaxis in cirrhosis: Good and bad. Hepatology, 2016.PMID 26528864
- [13]Singer M, Deutschman CS, Seymour CW, et al The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 2016.PMID 26903338
- [14]Kumar A, Roberts D, Wood KE, et al Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine, 2006.PMID 16625125
- [15]De Backer D, Biston P, Devriendt J, et al Comparison of dopamine and norepinephrine in the treatment of shock. New England Journal of Medicine, 2010.PMID 20200382
- [16]Brower RG, Matthay MA, Morris A, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. New England Journal of Medicine, 2000.PMID 10793162
- [17]Kirkpatrick AW, Roberts DJ, De Waele J, et al Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Medicine, 2013.PMID 23673399
- [18]Chiu YH, Chen JD, Tiu CM, et al Reappraisal of radiographic signs of pneumoperitoneum at emergency department. The American Journal of Emergency Medicine, 2009.PMID 19328377
- [19]Hadjivasilis A, Tzanis A, Ioakim KJ, et al The diagnostic accuracy of ascitic calprotectin for the early diagnosis of spontaneous bacterial peritonitis: systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology, 2021.PMID 32541235
- [20]Pericleous M, Sarnowski A, Moore A, et al The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. European Journal of Gastroenterology & Hepatology, 2016.PMID 26671516
- [21]Rimola A, Salmerón JM, Clemente G, et al Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology, 1995.PMID 7875666
- [22]Ginés P, Rimola A, Planas R, et al Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology, 1990.PMID 2210673
- [23]Yan T, Li SL, Ou HL, et al Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-Abdominal Candidiasis. World Journal of Surgery, 2020.PMID 31965275
- [24]Bass GA, Dzierba AL, Taylor B, et al Tertiary peritonitis: considerations for complex team-based care. European Journal of Trauma and Emergency Surgery, 2022.PMID 34302503
- [25]Kempf P, Bauernfeind A, Müller A, et al Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections. Infection, 1996.PMID 9007598